PDS Biotechnology closed an initial $11.3 million financing round led by Nant Capital and appointed Dr. Patrick Soon-Shiong to its board, using proceeds to repay debt, fund working capital, and advance the PDS0301 immunotherapy.
PDS Biotechnology closed an initial $11.3 million financing round led by Nant Capital and appointed Dr. Patrick Soon-Shiong to its board, using proceeds to repay debt, fund working capital, and advance the PDS0301 immunotherapy.